Low- but not high-dose FK506 treatment confers atheroprotection due to alternative macrophage activation and unaffected cholesterol levels
Bai, Lili, Gabriels, Karen, Wijnands, Erwin, Rousch, Mat, Daemen, Mat J. A. P., Cohen Tervaert, J. W., Biessen, Erik A. L., Heeneman, SylviaVolume:
104
Year:
2010
Language:
english
Journal:
Thrombosis and Haemostasis
DOI:
10.1160/TH09-07-0502
File:
PDF, 380 KB
english, 2010